|
Posted: 3/20/03; 12:19:34 AM
Novatia announced today that Integrated DNA Technologies (IDT) of Coralville, IA has agreed to purchase an Oligo HTCS
system from Novatia for use in high-throughput oligonucleotide QC.
Novatia's Oligo HTCS system is the first LC/MS system delivering total
automation - from sample prep to data analysis - for oligonucleotide
mass spectral characterization. IDT will use the Oligo HTCS LC/MS
system to analyze longer oligonucleotides, generally those greater than
50 bases in length, that are not amenable to analysis by existing
MALDI-ToF systems. IDT's evaluation of Novatia's system demonstrated
the unique capability to analyze oligos exceeding 130 bases in length
while maintaining 0.01% mass accuracy. IDT will use the Oligo HTCS to
compliment its industry-leading MALDI-ToF quality control services,
with state of the art QC of longmer oligos. IDT will also use the
system for detailed LC/MS profiling of research-oriented oligo samples.
IDT is an Iowa-based biotechnology company and a recognized force in
advancing biomedical research as both a supplier of custom
oligonucleotides and a developer of innovative new biotechnology. IDT's
automated synthesis laboratories have the capacity to produce over
25,000 oligos per day. As a leading manufacturer of synthetic DNA and
RNA, IDT provides products to over 60,000 customers worldwide.
Novatia, LLC is a New Jersey-based company that provides
state-of-the-art analytical solutions to the pharmaceutical,
biotechnology, and chemical industries. Novatia uses its expertise in
instrumentation, automation, software development, and analytical
chemistry to develop total analysis solutions that are based on
advanced analytical techniques such as LC/MS and NMR. Novatia also
uses its analytical methods and technology to provide analytical
services to a variety of analysis clients in the life science
industries.
Update! July, 2006. IDT now has nine Novatia Oligo HTCS systems in operation in their quality control laboratories in Coralville, IA and San Diego, CA.
|
